Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

REACH Worker Exposure Model for Co-formulants Used in Plant Protection Products.

Mostert V, Bonifay S, Dobe C, Fliege R, Krass J, Vosswinkel R, Wormuth M.

Ann Work Expo Health. 2019 Jan 7;63(1):54-67. doi: 10.1093/annweh/wxy088.

2.

Development of REACH Generic Exposure Scenarios for Substances Used as Coformulants in Plant Protection Products.

Dobe C, Bonifay S, Fliege R, Krass J, Mostert V, Vosswinkel R, Wormuth M.

Risk Anal. 2017 May;37(5):930-942. doi: 10.1111/risa.12666. Epub 2016 Jul 14.

PMID:
27411735
3.

Evaluation of carcinogenic potential of the herbicide glyphosate, drawing on tumor incidence data from fourteen chronic/carcinogenicity rodent studies.

Greim H, Saltmiras D, Mostert V, Strupp C.

Crit Rev Toxicol. 2015 Mar;45(3):185-208. doi: 10.3109/10408444.2014.1003423. Epub 2015 Feb 26. Review.

4.

Assessment of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption.

Aggarwal M, Battalora M, Fisher P, Hüser A, Parr-Dobrzanski R, Soufi M, Mostert V, Strupp C, Whalley P, Wiemann C, Billington R.

Regul Toxicol Pharmacol. 2014 Apr;68(3):412-23. doi: 10.1016/j.yrtph.2014.01.012. Epub 2014 Jan 31. Review.

PMID:
24491967
5.

Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes.

Forceville X, Mostert V, Pierantoni A, Vitoux D, Le Toumelin P, Plouvier E, Dehoux M, Thuillier F, Combes A.

Eur Surg Res. 2009;43(4):338-47. doi: 10.1159/000239763. Epub 2009 Sep 22.

6.

Selenium deficiency activates mouse liver Nrf2-ARE but vitamin E deficiency does not.

Burk RF, Hill KE, Nakayama A, Mostert V, Levander XA, Motley AK, Johnson DA, Johnson JA, Freeman ML, Austin LM.

Free Radic Biol Med. 2008 Apr 15;44(8):1617-23. doi: 10.1016/j.freeradbiomed.2008.01.016. Epub 2008 Jan 31.

7.

Serum iron increases with acute induction of hepatic heme oxygenase-1 in mice.

Mostert V, Nakayama A, Austin LM, Levander XA, Ferris CD, Hill KE, Burk RF.

Drug Metab Rev. 2007;39(2-3):619-26.

PMID:
17786642
8.

Selective induction of liver parenchymal cell heme oxygenase-1 in selenium-deficient rats.

Mostert V, Hill KE, Ferris CD, Burk RF.

Biol Chem. 2003 Apr;384(4):681-7.

PMID:
12751798
9.
10.

Identification of an element within the promoter of human selenoprotein P responsive to transforming growth factor-beta.

Mostert V, Wolff S, Dreher I, Köhrle J, Abel J.

Eur J Biochem. 2001 Dec;268(23):6176-81.

11.

Modulation of selenoprotein P expression by TGF-beta(1) is mediated by Smad proteins.

Mostert V, Dreher I, Köhrle J, Wolff S, Abel J.

Biofactors. 2001;14(1-4):135-42.

PMID:
11568450
12.

Cell-specific regulation of human aryl hydrocarbon receptor expression by transforming growth factor-beta(1).

Wolff S, Harper PA, Wong JM, Mostert V, Wang Y, Abel J.

Mol Pharmacol. 2001 Apr;59(4):716-24.

PMID:
11259615
13.

Selenoprotein P: properties, functions, and regulation.

Mostert V.

Arch Biochem Biophys. 2000 Apr 15;376(2):433-8. Review.

PMID:
10775431
14.

Transforming growth factor-beta1 inhibits expression of selenoprotein P in cultured human liver cells.

Mostert V, Dreher I, Kohrle J, Abel J.

FEBS Lett. 1999 Oct 22;460(1):23-6.

15.

Protection by selenoprotein P in human plasma against peroxynitrite-mediated oxidation and nitration.

Arteel GE, Mostert V, Oubrahim H, Briviba K, Abel J, Sies H.

Biol Chem. 1998 Aug-Sep;379(8-9):1201-5.

PMID:
9792455
16.

A novel method for the purification of selenoprotein P from human plasma.

Mostert V, Lombeck I, Abel J.

Arch Biochem Biophys. 1998 Sep 15;357(2):326-30.

PMID:
9735174

Supplemental Content

Loading ...
Support Center